{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:10:42Z","timestamp":1759558242764,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ejogrb.2014.10.033","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T22:07:12Z","timestamp":1414706832000},"page":"137-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Dual suppression with oral contraceptive pills in GnRH antagonist cycles for patients with polycystic ovary syndrome undergoing intracytoplasmic sperm injection"],"prefix":"10.1016","volume":"183","author":[{"given":"B.","family":"\u00d6zmen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.E.","family":"\u015e\u00fck\u00fcr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Seval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ate\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.S.","family":"Atabeko\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"S\u00f6nmezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Berker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2014.10.033_bib0005","first-page":"305","article-title":"PCOS and infertility","volume":"50","author":"Hart","year":"2008","journal-title":"Panminerva Med"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/humupd\/dml001","article-title":"GnRH antagonists in ovarian stimulation for IVF","volume":"12","author":"Tarlatzis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0015","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1472-6483(10)60652-9","article-title":"GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis","volume":"13","author":"Griesinger","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0020","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1472-6483(10)61059-0","article-title":"Gonadotrophin releasing hormone antagonists for assisted conception: a Cochrane review","volume":"14","author":"Al-Inany","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fertnstert.2004.06.076","article-title":"A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist\/recombinant follicle stimulating hormone (rFSH) versus GnRH-agonist\/rFSH in women pretreated with oral contraceptives before in vitro fertilization","volume":"83","author":"Barmat","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gyobfe.2009.04.028","article-title":"Efficacite de la programmation des cycles FIV en antagonists par les estrogenes","volume":"38","author":"Guivarc\u2019h-Leveque","year":"2010","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0035","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.fertnstert.2010.04.025","article-title":"Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis","volume":"94","author":"Griesinger","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0040","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00404-012-2348-9","article-title":"IVF\/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial","volume":"286","author":"Haydardedeo\u011flu","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0045","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0050","first-page":"15","article-title":"Hormonal responses to the new potent GnRH antagonist Cetrorelix","volume":"128","author":"Klingmuller","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0055","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1447-0756.2010.01247.x","article-title":"Comparison of gonadotropin releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients","volume":"36","author":"Hosseini","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1472-6483(10)60339-2","article-title":"A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS","volume":"15","author":"Aboulghar","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0065","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/humrep\/dei074","article-title":"Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome","volume":"20","author":"Ragni","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/09513590.2012.736561","article-title":"Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis","volume":"29","author":"Xiao","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0075","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0140-6736(01)06797-6","article-title":"Gonadotropin releasing hormone receptor antagonists","volume":"358","author":"Huirne","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1472-6483(10)60621-9","article-title":"Effect of an oral contraceptive pill on follicular development in IVF\/ICSI patients receiving a GnRH antagonist: a randomized study","volume":"13","author":"Huirne","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0085","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.fertnstert.2011.06.022","article-title":"Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial","volume":"96","author":"Garcia-Velasco","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.10.033_bib0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00404-010-1429-x","article-title":"Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOS patients","volume":"282","author":"Tehraninejad","year":"2010","journal-title":"Arch Gynecol Obstet"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514005570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514005570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:33:54Z","timestamp":1759556034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211514005570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":18,"alternative-id":["S0301211514005570"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.10.033","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual suppression with oral contraceptive pills in GnRH antagonist cycles for patients with polycystic ovary syndrome undergoing intracytoplasmic sperm injection","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}